earlier
establish
model
persist
viral
cn
infect
use
two
week
old
immunolog
normal
genet
unmodifi
mice
recombin
measl
viru
mv
use
model
infect
investig
role
regulatori
cell
treg
regul
immun
respons
brain
assess
whether
persist
cn
infect
modul
manipul
treg
peripheri
treg
expand
deplet
persist
phase
cn
infect
consequ
virusspecif
immun
respons
extent
persist
infect
analyz
virusspecif
cell
predominantli
recognis
b
present
viral
hemagglutinin
epitop
mvh
rivinrehl
quantifi
brain
pentam
stain
expans
treg
intraperiton
ip
applic
superagonist
antibodi
induc
transient
immunosuppress
caus
increas
viru
replic
spread
cn
contrast
deplet
treg
use
diphtheria
toxin
dt
dereg
deplet
regulatori
cell
mice
induc
increas
virusspecif
effector
cell
brain
caus
reduct
persist
infect
data
indic
manipul
treg
peripheri
util
regul
viru
persist
cn
role
regulatori
cell
treg
autoimmun
pathogeninduc
immun
respons
studi
intens
recent
year
import
tool
provid
discoveri
transcript
factor
forkhead
box
marker
treg
suppress
activ
acut
viral
infect
deplet
treg
found
prevent
develop
exhaust
cell
improv
immun
respons
addit
transient
deplet
treg
sever
persist
viral
infect
led
reactiv
virusspecif
cell
reduct
viru
load
import
protect
role
treg
overshoot
immun
respons
cn
becam
obviou
anim
model
stroke
experiment
autoimmun
enceph
human
immunodefici
associ
neurodegener
reduc
astrogliosi
microgliamedi
inflamm
interestingli
virus
even
develop
strategi
support
expans
treg
order
suppress
antivir
cytotox
cell
ctl
respons
limit
viral
immunopathogenesi
defect
regul
number
activ
treg
also
involv
number
human
autoimmun
diseas
type
diabet
rheumatoid
arthriti
multipl
sclerosi
viral
infect
brain
mostli
repres
clinic
import
often
lifethreaten
complic
system
viral
infect
exampl
acut
measl
cn
complic
may
occur
earli
acut
postinfecti
enceph
year
viral
persist
subacut
scleros
panenceph
sspe
epidemiolog
studi
indic
primari
mv
infect
sspe
patient
take
place
predominantli
age
two
year
immun
system
host
still
immatur
residu
matern
antibodi
may
absent
suffici
complet
viru
neutral
intracerebr
mv
infect
mice
transgen
human
receptor
mv
necessarili
requir
variou
infect
model
exist
depend
age
mice
viru
strain
infecti
dose
found
genet
unmodifi
mvreceptor
transgen
mice
cell
ifnc
critic
role
protect
clearanc
viru
brain
transient
immunosuppress
mvinfect
enhanc
viru
replic
facilit
persist
intranas
infect
mvreceptor
mice
specif
antivir
cellular
immun
respons
includ
increas
proport
treg
spleen
observ
although
presenc
activ
treg
demonstr
actual
role
viral
immunosuppress
immunopathogenesi
brain
remain
elucid
investig
role
treg
viru
persist
cn
accord
model
two
week
old
mice
age
mice
surviv
infect
immun
system
still
fulli
matur
intracerebr
infect
viru
persist
limit
number
neuron
anim
week
expand
deplet
treg
peripheri
persist
phase
viral
infect
investig
whether
exploit
modul
hidden
cn
infect
data
indic
inde
case
manipul
treg
util
regul
virusspecif
effector
cell
viru
persist
brain
regulatori
cell
present
predominantli
spleen
lymph
node
low
frequenc
also
brain
two
week
old
mice
intracerebr
ic
infect
pfu
recombin
mv
express
rodent
brainadapt
haemagglutinin
camh
egfp
indic
recombin
mv
without
egfp
recombin
virus
rmv
edtag
egfpcamh
rmv
edtag
camh
distinct
tropism
mous
neuron
infect
caus
similar
acut
persist
cn
infect
recombin
virus
design
throughout
manuscript
rmvgreen
rmv
determin
number
treg
present
infect
model
secondari
lymphoid
organ
brain
mice
infect
rmvgreen
analyz
day
post
infect
lymphocyt
isol
drain
cervic
lymph
node
ln
spleen
brain
mvinfect
control
ic
inject
pb
anim
fraction
cell
lymphocyt
determin
spleen
ln
fig
b
signific
differ
infect
control
anim
correspond
total
number
treg
approxim
spleen
prepar
ln
day
post
infect
small
statist
signific
number
cell
detect
brain
irrespect
infect
data
shown
obtain
statist
signific
result
reduc
standard
error
caus
stain
procedur
use
dereg
mice
express
gfp
cell
infect
mice
rmv
express
gfp
small
signific
number
gfp
cell
approxim
per
brain
detect
brain
wherea
almost
gfp
cell
detect
control
order
find
whether
treg
influenc
persist
cn
infect
first
expand
function
activ
treg
use
superagonist
monoclon
antibodi
clone
mab
mab
caus
transient
expans
total
lymph
node
splenic
cell
popul
predominantli
expand
function
treg
without
caus
system
cytokin
releas
order
test
effici
mab
young
mice
measur
treg
preliminari
experi
uninfect
mice
day
singl
ip
inject
mg
flow
cytometri
proport
treg
increas
spleen
lymph
node
approxim
fig
n
result
indic
mab
use
expans
treg
also
young
mice
follow
experi
investig
effect
mab
persist
viral
infect
appli
mg
day
post
infect
analyz
brain
dpi
fig
b
condit
total
number
lymphocyt
increas
significantli
treatment
spleen
ln
brain
fig
c
furthermor
proport
treg
increas
significantli
approxim
spleen
ln
fig
interestingli
histolog
analyz
reveal
extent
viral
infect
increas
consider
treatment
larg
cluster
group
bright
gfpposit
directli
reflect
viru
replic
infect
neuron
emerg
brain
mice
fig
strike
contrast
brain
untreat
mice
dpi
contain
limit
number
infect
neuron
fig
b
also
strikingli
differ
brain
dpi
treatment
begin
time
point
area
weak
vanish
gfp
express
observ
repres
area
viru
elimin
fig
c
quantif
demonstr
approxim
infect
cell
per
brain
anim
comparison
control
anim
dpi
fig
compar
lane
differ
highli
signific
two
week
later
dpi
number
infect
cell
reduc
still
higher
control
anim
deplet
treg
use
transgen
mice
express
human
diphtheria
toxin
dt
receptor
control
treat
dt
elimin
specif
treg
deregmic
test
activ
dtbatch
use
adult
dereg
mice
pilot
experi
treat
dt
standard
condit
mg
dt
ip
inject
consecut
day
analyz
next
day
lymphocyt
isol
spleen
lymph
node
analyz
flow
cytometri
demonstr
success
deplet
gfp
treg
fig
order
assess
effect
treg
deplet
viru
persist
young
mice
persist
infect
mice
treat
consecut
day
day
post
infect
mg
dt
analyz
day
post
infect
fig
b
mice
viral
infect
quantifi
histolog
subsequ
brain
slice
complet
cerebrum
describ
earlier
treg
deplet
dereg
mice
compar
dt
treat
dereg
mice
control
anim
led
signific
reduct
number
infect
neuron
brain
persist
infect
anim
n
p
fig
c
order
investig
whether
increas
viru
clearanc
correl
presenc
higher
number
virusspecif
cell
first
identifi
cell
receptor
recogn
peptid
present
mhc
class
mice
b
two
cell
detect
brain
dpi
fig
interestingli
high
percentag
b
mvh
cell
present
brain
persist
phase
infect
dpi
approxim
lymphocyt
mocktreat
anim
ic
pb
inject
ctrl
contain
virusspecif
cell
treatment
dereg
mice
dt
number
treg
decreas
approxim
number
cell
brain
slightli
increas
fig
b
interestingli
deplet
treg
fraction
absolut
number
b
mvh
specif
cell
increas
cell
per
brain
cell
n
p
fig
c
thu
deplet
treg
persist
phase
infect
led
increas
virusspecif
cell
signific
reduct
persist
infect
brain
result
indic
immun
system
keep
hidden
persist
viral
cn
infect
perman
control
manipul
treg
peripheri
signific
consequ
fate
viral
infect
brain
although
infect
neuron
present
persist
phase
infect
expand
number
treg
superagonist
antibodi
led
activ
viru
replic
dramat
increas
number
infect
neuron
wherea
transient
deplet
treg
dt
led
signific
reduct
number
infect
neuron
interestingli
complet
elimin
viru
clearanc
infect
achiev
transient
deplet
treg
suggest
addit
mean
antivir
immun
respons
requir
complet
clearanc
look
treg
brain
detect
signific
number
treg
facsanalysi
stain
antibodi
small
number
gfp
figur
expans
lymphocyt
superagonist
antibodi
induc
viru
replic
spread
consecut
coron
brain
section
mm
section
prepar
complet
rmvgreeninfect
mous
cerebra
analyz
use
uv
microscop
overview
detail
typic
section
infect
brain
mous
treat
mab
analyz
dpi
section
infect
control
anim
absenc
mab
dpi
b
dpi
c
shown
number
infect
egfp
cell
per
brain
section
complet
cerebrum
anim
evalu
describ
determin
microscop
infect
control
mice
dpi
lane
mice
dpi
lane
differ
control
mice
dpi
highli
signific
express
cell
infect
dereg
mice
find
suggest
treg
requir
within
brain
regul
effector
immun
cell
regul
predominantli
take
place
secondari
lymphoid
organ
sellin
et
al
observ
increas
treg
consequ
mv
infect
mice
spleen
brain
suggest
also
mvinfect
support
expans
migrat
treg
infectioninduc
treg
may
part
multifactori
mvinduc
immunosuppress
treg
restrain
effector
cell
respons
product
immunomodulatori
cytokin
tgfb
express
inhibitori
ligand
cytokin
consumpt
direct
cytolysi
remain
elucid
mechan
involv
persist
brain
infect
mv
sever
report
support
view
cell
play
decis
role
control
viral
cn
infect
use
primari
human
lymphocyt
vitro
experi
demonstr
lymphocyt
control
dissemin
mv
resist
mous
strain
deplet
cell
subset
monoclon
antibodi
led
breakdown
resist
infect
wherea
deplet
cell
effect
taptransport
defici
mice
present
antigen
mhc
class
molecul
mv
found
spread
transneuron
brain
normal
mice
find
indic
infect
neuron
target
cell
lymphocyt
brain
infect
extent
inhibit
ctl
activ
investig
reveal
cell
abl
protect
either
alon
resist
mous
strain
cooper
cell
mice
intermedi
suscept
cell
abl
protect
alon
immun
mice
use
ragdefici
mice
adopt
transfer
lymphocyt
reveal
combin
activ
lymphocyt
cell
b
cell
requir
control
intracerebr
infect
thu
find
support
view
cell
play
import
role
control
transneuron
viru
spread
find
suggest
mvspecif
cell
involv
maintain
steadi
state
control
infect
persist
phase
cn
infect
studi
carri
strict
accord
recommend
guid
care
use
control
dereg
mice
infect
ic
rmvgreen
treat
dt
reduct
mean
valu
signific
p
number
infect
egfp
cell
per
brain
determin
microscop
evalu
mm
section
complet
cerebrum
describ
laboratori
anim
nation
institut
health
protocol
approv
committe
ethic
anim
experi
univers
permit
number
specif
pathogen
free
mice
purchas
harlanwinkelmann
germani
dereg
mice
breed
anim
facil
institut
virolog
immunobiolog
centr
experiment
medicin
mice
anesthet
use
isofluran
infect
intracerebr
ic
left
hemispher
ml
viru
suspens
contain
pfu
age
two
week
expand
treg
mice
treat
intraperiton
ip
mg
superagonist
monoclon
antibodi
mab
deplet
treg
dereg
mice
treat
ip
mg
diphtheria
toxin
dt
merck
vero
cell
african
green
monkey
atcc
crl
cultur
eagl
minim
essenti
medium
mem
contain
fetal
calf
serum
fc
uml
penicillin
mgml
streptomycin
recombin
measl
virus
express
rodent
adapt
haemagglutinin
strain
camrb
camh
andor
enhanc
green
fluoresc
protein
egfp
rmv
edtag
egfpcamh
rmvgreen
rmv
edtag
camh
rmv
propag
use
vero
cell
analyz
anim
anesthet
co
perfus
wv
paraformaldehyd
pfa
brain
fix
pfa
least
h
freefloat
section
mm
prepar
use
vibratom
technic
product
intern
describ
slice
analyz
directli
uv
microscopi
photomicrograph
taken
digit
camera
leica
number
infect
egfpposit
neuron
count
statist
analyz
done
use
student
test
program
prism
graphpad
inc
isol
lymphocyt
lymph
node
spleen
brain
drain
cervic
lymph
node
spleen
press
steel
siev
ml
hbss
homogen
total
volum
ml
hbss
centrifug
step
g
min
cell
pellet
resuspend
adequ
volum
hbss
approxim
cellsml
spleen
cell
addit
treat
erythrocyt
lysi
buffer
mm
nh
cl
mm
khco
mm
edta
wash
hbss
brain
press
steel
siev
ml
hbss
fc
homogen
total
volum
ml
hbss
fc
centrifug
step
g
min
cell
pellet
resuspend
ml
dissoci
buffer
mm
cacl
mm
kcl
mm
mgcl
mm
nacl
contain
u
collagenas
serva
u
benzonas
novagen
incub
h
afterward
cell
wash
hbss
appli
percol
densiti
gradient
separ
lymphocyt
rest
like
myelin
debri
neuron
cell
describ
lymphocyt
isol
wash
remov
percol
subsequ
analyz
mous
clone
clone
clone
clone
clone
antibodi
purchas
becton
dickinson
peconjug
antimous
clone
antibodi
purchas
natutec
lymphocyt
stain
fac
buffer
pb
contain
bsa
sodium
azid
min
intracellular
stain
perform
use
stain
buffer
set
natutec
accord
manufactur
protocol
briefli
cell
fix
permeabil
ml
fixationpermeabil
buffer
concentratedilu
rt
h
stain
afterward
permeabil
buffer
rt
min
flow
cytometr
analysi
perform
facscalibur
becton
dickinson
identif
peptid
present
mhc
class
use
elispot
pentam
stain
experi
use
softwar
program
syfpeithi
univers
germani
bima
bioinformat
molecular
analysi
section
nation
health
institut
bethesda
usa
establish
rank
potenti
peptid
potenti
k
b
bpresent
peptid
mvn
mvh
highest
probabl
score
found
b
mvh
b
mvh
rivinrehl
snhnnvywl
respect
effici
recogn
elispot
experi
perform
use
mous
ifnc
elispot
set
bd
bioscienc
accord
manufactur
protocol
mhc
class
b
pentam
present
select
peptid
mvh
b
mvh
pentam
order
proimmun
ltd
oxford
uk
cell
wash
fac
buffer
stain
ml
pentamersolut
dilut
ml
fac
buffer
min
one
wash
step
cell
analyz
use
facscalibur
mvspecif
cell
gate
lymphocyt
exclud
pentam
cell
